Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Join SI Premium – FREE
Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $11.87 million versus the consensus estimate of $13.08 million.
For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Galaxy Digital (GLXY) call put ratio 3.8 calls to 1 put with a focus on November 27 weekly 18 and December 16 calls
- J.B. Hunt Transport Services (JBHT) Declares $0.45 Quarterly Dividend; 0.8% Yield
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
